It was the first day of dealing on Aim for Castor Investments, a shell company backed by Barry Muncaster, the man behind BioProgress, down ½p at 75½p. It follows an introduction of shares in Castor - which will focus on acquisitions in the healthcare and lifesciences industry - by broker Teather & Greenwood at 5p. The price more than doubled to 10.25p.